Bacterial contamination of needle points after intravitreal injection

European Journal of Ophthalmology

Volumn 19, Issue 2, 2009, Pages 268-272

  Nentwich, Martin M ^a   Yactayo Miranda, Yazmin ^a   Weimann, Steffen ^a   Fröhlich, Stephan ^a   Wolf, Armin ^a   Kampik, Anselm ^a   De Kaspar, Herminia Mino ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacterial contamination; Intravitreal injections; Microbiology; Preoperative prophylaxis

Indexed keywords

AMOXICILLIN; AMPICILLIN; BEVACIZUMAB; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; FOSFOMYCIN; GENTAMICIN; LEVOFLOXACIN; MOXIFLOXACIN; NORFLOXACIN; OXACILLIN; PEGAPTANIB; PENICILLIN G; POVIDONE IODINE; RANIBIZUMAB; TETRACYCLINE; THIOGLYCOLIC ACID; TOBRAMYCIN; TRIAMCINOLONE ACETONIDE; VANCOMYCIN; ANGIOGENESIS INHIBITOR; ANTIINFECTIVE AGENT;

AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONJUNCTIVA; CONTROLLED STUDY; CORYNEBACTERIUM; DISINFECTION; EYE CARE; EYE LAVAGE; EYELASH; EYELID; FEMALE; FOREHEAD; HUMAN; INCUBATION TIME; INFECTION PREVENTION; INTRAVITREAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NEEDLE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; BACTERIAL COUNT; DRUG EFFECT; EQUIPMENT; INCIDENCE; INJECTION; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; STATISTICS; VITREOUS BODY;

AGED; ANGIOGENESIS INHIBITORS; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; CONJUNCTIVA; CORYNEBACTERIUM; DISINFECTION; EQUIPMENT CONTAMINATION; FEMALE; HUMANS; INCIDENCE; INJECTIONS; MALE; MICROBIAL SENSITIVITY TESTS; NEEDLES; STAPHYLOCOCCUS EPIDERMIDIS; VITREOUS BODY;

EID: 65249135635     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210901900215     Document Type: Article

References (20)

1. Moshfeghi DM, Kaiser PK, Scott IU, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003; 136: 791-6.
2. Jager RD, Aiello LP, Patel SC, Cunningham ET Jr. Risks of intravitreous injection: a comprehensive review. Retina 2004; 24: 676-98.
3. Wu L, Martinez-Castellanos MA, Quiroz-Mercado H, et al. Twelve-month safety of intravitreal injections of bevacizumab (Avastin(R)): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol 2007; 246: 81-7.
4. Westfall AC, Osborn A, Kuhl D, Benz MS, Mieler WF, Holz ER. Acute endophthalmitis incidence: intravitreal triamcinolone. Arch Ophthalmol 2005; 123: 1075-7.
5. Baath J, Ells AL, Crichton A, Kherani A, Williams RG. Safety profile of intravitreal triamcinolone acetonide. J Ocul Pharmacol Ther 2007; 23: 304-10.
6. Bhavsar AR, Ip MS, Glassman AR. The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials. Am J Ophthalmol 2007; 144: 454-6.
7. Tervo T, Ljungberg P, Kautiainen T, et al. Prospective evaluation of external ocular microbial growth and aqueous humor contamination during cataract surgery. J Cataract Refract Surg 1999; 25: 65-71.
8. Speaker MG, Milch FA, Shah MK, Eisner W, Kreiswirth BN. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 1991; 98: 639-49.
9. Aiello LP, Brucker AJ, Chang S, et al. Evolving guidelines for intravitreous injections. Retina 2004; 24: S3-19.
10. Jaissle GB, Szurman P, Bartz-Schmidt KU. Recommendation for the implementation of intravitreal injections: statement of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA). Klin Monatsbl Augenheilkd 2005; 222: 390-5.
11. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004; 351: 2805-16.
12. de Kaspar HM, Chang RT, Shriver EM, et al. Three-day application of topical ofloxacin reduces the contamination rate of microsurgical knives in cataract surgery: a prospective randomized study. Ophthalmology 2004; 111: 1352-5.
13. Carothers TS, Coats DK, McCreery KM, et al. Quantification of incidental needle and suture contamination during strabismus surgery. Binocul Vis Strabismus Q 2003; 18: 75-9.
14. Olitsky SE, Vilardo M, Awner S, Reynolds JD. Needle sterility during strabismus surgery. J AAPOS 1998; 2: 151-2.
15. Scott IU, Flynn HW Jr. Reducing the risk of endophthalmitis following intravitreal injections. Retina 2007; 27: 10-2.
16. Maeck CR, Eckardt C, Holler C. Preoperative disinfection of the conjunctiva with PVP-iodine. Fortschr Ophthalmol 1990; 87: 320-3.
17. Ta CN, Egbert PR, Singh K, Shriver EM, Blumenkranz MS, Mino DK. Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery. Ophthalmology 2002; 109: 2036-40.
18. de Caro JJ, Ta CN, Ho HK, et al. Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections. Retina 2008; 28: 877-83.
19. Deramo VA, Lai JC, Fastenberg DM, Udell IJ. Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin. Am J Ophthalmol 2006; 142: 721-5.
20. Ta CN. Topical antibiotic prophylaxis in intraocular injections. Arch Ophthalmol 2007; 125: 972-4.